* Definitive Healthcare Corp DH.OQ DH.O is expected
to report
results on May 5.
* The Framingham Massachusetts-based company is expected to
report revenue of $48.465 million, according to the mean
estimate from 10 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Definitive
Healthcare
Corp is for earnings of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 2.3%
in the last three months.
* Wall Street's median 12-month price target for Definitive
Healthcare Corp is $27.5, above its last closing price
of $23.26.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 0.04 0.04 0.04 Met -7.4
Sep. 30 2021 0.02 0.02 0.01 Missed -47.4
This summary was machine generated May 4 at 02:03 GMT. All
figures in US dollars unless otherwise stated